abstract |
The present invention provides for the treatment, prevention and/or reduction of risk of diseases, disorders or conditions involving aldehyde toxicity in their pathogenesis, including ocular disorders, Skin disorders, conditions associated with the deleterious effects of caustic agents, as well as autoimmune, inflammatory, neurological and cardiovascular diseases. |